HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Microvena's Trap VFS

This article was originally published in The Gray Sheet

Executive Summary

Vascular filtration system for use during angioplasty and stenting procedures in saphenous vein bypass grafts is anticipated to debut in Europe in the fourth quarter following CE mark approval in July. Phase I multi-center randomized U.S. trials commenced in June, and enrollment should be complete by the end of year, the firm says. In contrast to distal protection systems that use occlusion balloons, the device's self-expanding nitinol filter, placed downstream of the target lesion, captures debris while allowing blood to continue to flow uninterrupted, according to the company. Microvena expects to launch the Trap in the U.S. by late 2001 or early 2002
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT013788

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel